XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Revenue $ 756,217 $ 1,100,152 $ 2,918,271 $ 3,394,934
Cost of revenue 815,871 1,619,801 3,200,996 5,219,993
Gross loss (59,654) (519,649) (282,725) (1,825,059)
Selling expenses 78,041 134,603 266,444 354,245
General and administrative expenses 424,827 345,051 1,372,843 925,377
Research and development expenses 40,321 87,610 90,860 283,395
Credit losses (reversal of allowance for credit losses) 25,302 (1,656) 26,011 4,754
Total operating expenses 568,491 565,608 1,756,158 1,567,771
Loss from operations (628,145) (1,085,257) (2,038,883) (3,392,830)
Other income (expense):        
Research and development subsidy 415 151,105
Interest income 294 1,460 1,790 5,306
Interest expense (24,046) (34,114) (79,433) (124,409)
Net other (expense) income (23,337) (32,654) 73,462 (119,103)
Loss before income taxes (651,482) (1,117,911) (1,965,421) (3,511,933)
Income tax expense
Net loss (651,482) (1,117,911) (1,965,421) (3,511,933)
Other comprehensive income - foreign currency translation adjustment 57,335 137,638 85,114 70,561
Comprehensive loss $ (594,147) $ (980,273) $ (1,880,307) $ (3,441,372)
Loss per share:        
Loss per share Basic (in Dollars per share) $ (0.17) $ (0.65) $ (0.57) $ (2.25)
Loss per share Diluted (in Dollars per share) $ (0.17) $ (0.65) $ (0.57) $ (2.25)
Weighted average shares outstanding (in Shares) 3,874,085 1,730,672 3,468,211 1,559,347